These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8110956)

  • 1. Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion).
    Dietze R; Milan EP; Berman JD; Grogl M; Falqueto A; Feitosa TF; Luz KG; Suassuna FA; Marinho LA; Ksionski G
    Clin Infect Dis; 1993 Dec; 17(6):981-6. PubMed ID: 8110956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of kala-azar in Brazil with Amphocil (amphotericin B cholesterol dispersion) for 5 days.
    Dietze R; Fagundes SM; Brito EF; Milan EP; Feitosa TF; Suassuna FA; Fonschiffrey G; Ksionski G; Dember J
    Trans R Soc Trop Med Hyg; 1995; 89(3):309-11. PubMed ID: 7660446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of visceral leishmaniasis with amphotericin B colloidal dispersion.
    Berman J; Dietze R
    Chemotherapy; 1999 Jun; 45 Suppl 1():54-66. PubMed ID: 10394022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis.
    Berman JD; Ksionski G; Chapman WL; Waits VB; Hanson WL
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1978-80. PubMed ID: 1416890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cure of antimony-unresponsive Indian visceral leishmaniasis with amphotericin B lipid complex.
    Sundar S; Murray HW
    J Infect Dis; 1996 Mar; 173(3):762-5. PubMed ID: 8627049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries.
    Berman JD; Badaro R; Thakur CP; Wasunna KM; Behbehani K; Davidson R; Kuzoe F; Pang L; Weerasuriya K; Bryceson AD
    Bull World Health Organ; 1998; 76(1):25-32. PubMed ID: 9615494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable paromomycin for Visceral leishmaniasis in India.
    Sundar S; Jha TK; Thakur CP; Sinha PK; Bhattacharya SK
    N Engl J Med; 2007 Jun; 356(25):2571-81. PubMed ID: 17582067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized comparison of classical mode of administration of amphotericin B with its newer modes of administration in kala-azar.
    Thakur CP; Kumar P; Kumar N; Singh GN; Singh AK; Narain S
    J Assoc Physicians India; 1998 Sep; 46(9):779-83. PubMed ID: 11229246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphotericin B in resistant kala-azar in Bihar.
    Thakur CP; Sinha GP; Pandey AK; Barat D; Sinha PK
    Natl Med J India; 1993; 6(2):57-60. PubMed ID: 8477209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cumulative cardiac toxicity of sodium stibogluconate and amphotericin B in treatment of kala-azar.
    Maheshwari A; Seth A; Kaur S; Aneja S; Rath B; Basu S; Patel R; Dutta AK
    Pediatr Infect Dis J; 2011 Feb; 30(2):180-1. PubMed ID: 20823781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme.
    Hossain MS; Kumar A; Hossain AFMA; Mahshin M; Sharma A; Hossain MA; Sharma V; Haque R; Shamsuzzaman AKM; Maruf S; Ghosh P; Ahuja V; Mondal D
    Infect Dis Poverty; 2018 Aug; 7(1):80. PubMed ID: 30099967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving outcome of treatment of kala-azar by supplementation of amphotericin B with physiologic saline and potassium chloride.
    Thakur CP; Kumar A; Mitra DK; Roy A; Sinha AK; Ranjan A
    Am J Trop Med Hyg; 2010 Nov; 83(5):1040-3. PubMed ID: 21036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial.
    Sundar S; Agrawal G; Rai M; Makharia MK; Murray HW
    BMJ; 2001 Aug; 323(7310):419-22. PubMed ID: 11520836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL).
    Musa AM; Khalil EA; Mahgoub FA; Hamad S; Elkadaru AM; El Hassan AM
    Ann Trop Med Parasitol; 2005 Sep; 99(6):563-9. PubMed ID: 16156969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-course, cost-effective treatment with amphotericin B-fat emulsion cures visceral leishmaniasis.
    Sundar S; Gupta LB; Rastogi V; Agrawal G; Murray HW
    Trans R Soc Trop Med Hyg; 2000; 94(2):200-4. PubMed ID: 10897369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study.
    Thakur CP
    Int J Antimicrob Agents; 2001 Jan; 17(1):67-70. PubMed ID: 11137652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-dose liposomal amphotericin B for visceral leishmaniasis in India.
    Sundar S; Chakravarty J; Agarwal D; Rai M; Murray HW
    N Engl J Med; 2010 Feb; 362(6):504-12. PubMed ID: 20147716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Observations on amphotericin B treatment of kala-azar given in a rural set up in Bihar, India.
    Thakur CP; Ahmed S
    Indian J Med Res; 2001 Jan; 113():14-8. PubMed ID: 11280166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study.
    Sundar S; Jha TK; Thakur CP; Mishra M; Singh VR; Buffels R
    Am J Trop Med Hyg; 2002 Feb; 66(2):143-6. PubMed ID: 12135284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.
    Sundar S; Sinha PK; Rai M; Verma DK; Nawin K; Alam S; Chakravarty J; Vaillant M; Verma N; Pandey K; Kumari P; Lal CS; Arora R; Sharma B; Ellis S; Strub-Wourgaft N; Balasegaram M; Olliaro P; Das P; Modabber F
    Lancet; 2011 Feb; 377(9764):477-86. PubMed ID: 21255828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.